Vandana Laboratories Private Limited
About Vandana Laboratories Private Limited
Data last updated:
Vandana Laboratories Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 March 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1994PTC057689.
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹2.16 Cr. It is led by directors Rajesh Bansal and Ram Niwas Bansal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at M – 116 2nd Floor Connaught Place, New Delhi, Delhi, India – 110001.
As per the financials filed for FY 2024, the company reported a revenue of ₹15,500, a decline of 100% compared to the previous year. For the same year it recorded a net loss of ₹1.8 Lakh and EBITDA of -₹1.8 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 1% over five years.
As per MCA filings, the company has open charges of ₹117.84 Cr and satisfied charges of ₹117.84 Cr on record. Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Vandana Laboratories Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressM – 116 2nd Floor Connaught Place, New Delhi, Delhi, India – 110001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Vandana Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Vandana Laboratories Private Limited
FY 2025 filings availableVandana Laboratories Private Limited reported revenue of ₹15,500 (down 100% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 1% over five years. EBITDA rose 81% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.8 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.8 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vandana Laboratories Private Limited, buy the company report.
Board of directors of Vandana Laboratories Private Limited
Vandana Laboratories has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Bansal Also directs: Viresh Buildcon LLP, Kumar Ice Factory Private Limited, Nuevo Nextra Developers Private Limited and 5 more | Director | 26 Mar 2007 | 19 Years 7 Months | Current |
| Ram Niwas Bansal Also directs: Viresh Buildcon LLP, Kumar Ice Factory Private Limited, Supreme Structures Private Limited and 5 more | Director | 20 Aug 2015 | 11 Years 2 Months | Current |
Peer comparison
Vandana Laboratories Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vandana Laboratories Private Limitedthis company | ₹15,500 (FY 2024) | -₹1.8 Lakh | -100.0% | New Delhi, Delhi, India | ||
| Sakksa Pharma Private Limited | ₹15,400 (FY 2025) | Hyderabad, Telangana, India | ||||
| Humana Formulations Private Limited | ₹15,230 (FY 2018) | -90.0% | Vadodara, Gujarat, India | |||
| VRX World Pharmacy Private Limited | ₹15,000 (FY 2025) | Delhi, India | ||||
| Jyostna Laboratories Private Limited | ₹15,000 (FY 2024) | 0.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Vandana Laboratories Private Limited, buy the company report.
Auditor
Vandana Laboratories Private Limited is audited by AGARWAL & GUPTA for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AGARWAL & GUPTA | FY 2021 | 017621C |
Shareholding
The shareholding of Vandana Laboratories Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Vandana Laboratories Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 03 Feb 2011 | 10270015 | Union Bank of India | ₹117.84 Cr | Satisfied |
To see the full charge records of Vandana Laboratories Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Vandana Laboratories Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Tax appeal | Filed against the company by an individual | Disposed |
To see the full case history of Vandana Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vandana Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Vandana Laboratories Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Vandana Laboratories Private Limited has 5 board changes on record since 2007: 2 appointments and 3 cessations. The latest: Ram Niwas Bansal ceased to be Additional Director on 29 Sep 2015.
Frequently asked questions
Vandana Laboratories is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 March 1994 (32+ years old) and is registered under CIN U74899DL1994PTC057689.
Vandana Laboratories has 2 current directors:
- Rajesh Bansal - Director
- Ram Niwas Bansal - Director
The latest financial statements of Vandana Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Vandana Laboratories is U74899DL1994PTC057689. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vandana Laboratories has 1 court case on record: 1 filed against it.
Vandana Laboratories was incorporated on 03 March 1994, making it 32+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Vandana Laboratories by revenue are Sakksa Pharma Private Limited, Humana Formulations Private Limited, VRX World Pharmacy Private Limited, Jyostna Laboratories Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ram Niwas Bansal ceased to be Additional Director on 29 Sep 2015. Gaurav Bansal ceased to be Additional Director on 20 Aug 2015. Ram Niwas Bansal was appointed as Director on 20 Aug 2015. Vandana Laboratories has 5 board changes on record in total.
The registered office of Vandana Laboratories is at M – 116 2nd Floor Connaught Place, New Delhi, Delhi, India – 110001.
Vandana Laboratories operates in the pharma industry, in the drug formulation and development segment.
Vandana Laboratories has open charges of ₹117.84 Cr and satisfied charges of ₹117.84 Cr as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
